| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |